Marc Buyse
ScD
Founder and Chief Scientific Officer
👥Biography 个人简介
Marc Buyse is a biostatistician who has made foundational contributions to surrogate endpoint validation and meta-analysis in oncology. He developed generalized pairwise comparisons for prioritized endpoints. His work has shaped how surrogate endpoints such as DFS and pCR are used in oncology drug development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Marc Buyse 的研究动态
Follow Marc Buyse's research updates
留下邮箱，当我们发布与 Marc Buyse（International Drug Development Institute (IDDI)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment